fashion -WSS

fashion

author：Wikipedia 2025-09-29 00:39:11 - browse：12

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

knowledge

hotspot

explore

WSS

Malaria cases in Florida and Texas: Here’s what you need to know

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

How Medicaid coverage policies for immigrants impact new moms

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

In age of alternative facts, a scholarly course on calling out crap

Why hospitals are withdrawing from US News rankings

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

The high cost of giving birth even with insurance

State Dept. review finds Biden bears some blame for Afghanistan failures

23andMe had bad news about my health. I wish a person had delivered it

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Psychedelics group wrestles with new pharma identity

Medical leaders decry Supreme Court decision on affirmative action

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Hollywood unions extend contract negotiations for actors

Medical records are filled with copy

Medical leaders decry Supreme Court decision on affirmative action

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Dobbs anniversary: the lost opportunity of abortion as health care

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cancer drug shortages should be causing more outrage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In Memoriam: Notable people who died in 2023

knowledge

hotspot

explore

knowledge